LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+46.13%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$899M
AUM Growth
+$899M
Cap. Flow
+$9.42M
Cap. Flow %
1.05%
Top 10 Hldgs %
62.68%
Holding
71
New
17
Increased
10
Reduced
14
Closed
22

Top Buys

1
ARGX icon
argenx
ARGX
$55.2M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
$35.3M
3
CYTK icon
Cytokinetics
CYTK
$31.3M
4
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$28.3M
5
GPCR icon
Structure Therapeutics
GPCR
$23.2M

Top Sells

1
ICVX
Icosavax, Inc. Common Stock
ICVX
$38.9M
2
SRPT icon
Sarepta Therapeutics
SRPT
$24.2M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
$21M
4
NBIX icon
Neurocrine Biosciences
NBIX
$16.9M
5
IMVT icon
Immunovant
IMVT
$16.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALLK
26
DELISTED
Allakos
ALLK
$7.92M 0.74%
2,900,000
-1,750,000
-38% -$4.78M
TRML icon
27
Tourmaline Bio
TRML
$624M
$7.44M 0.69%
+284,372
New +$7.44M
RNA icon
28
Avidity Biosciences
RNA
$5.98B
$7.01M 0.65%
+775,000
New +$7.01M
SLN
29
Silence Therapeutics
SLN
$236M
$6.95M 0.65%
+400,000
New +$6.95M
XENE icon
30
Xenon Pharmaceuticals
XENE
$3.05B
$6.91M 0.64%
150,000
-300,000
-67% -$13.8M
NMRA icon
31
Neumora Therapeutics
NMRA
$280M
$6.52M 0.61%
+382,345
New +$6.52M
RCUS icon
32
Arcus Biosciences
RCUS
$1.22B
$6.21M 0.58%
+325,000
New +$6.21M
MORF
33
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5.78M 0.54%
+200,000
New +$5.78M
APLT icon
34
Applied Therapeutics
APLT
$74.9M
$5.56M 0.52%
+1,660,000
New +$5.56M
VTYX icon
35
Ventyx Biosciences
VTYX
$183M
$4.94M 0.46%
2,000,000
+1,775,000
+789% +$4.38M
ICVX
36
DELISTED
Icosavax, Inc. Common Stock
ICVX
$4.73M 0.44%
300,000
-2,465,741
-89% -$38.9M
RPTX icon
37
Repare Therapeutics
RPTX
$73.9M
$4.38M 0.41%
600,000
+300,000
+100% +$2.19M
CMPS
38
Compass Pathways
CMPS
$449M
$4.38M 0.41%
500,000
-450,000
-47% -$3.94M
ELVN icon
39
Enliven Therapeutics
ELVN
$1.24B
$4.25M 0.4%
307,076
– –
ATXS icon
40
Astria Therapeutics
ATXS
$388M
$4.19M 0.39%
544,960
– –
INBX
41
DELISTED
Inhibrx, Inc. Common Stock
INBX
$3.8M 0.35%
+100,000
New +$3.8M
SYRE icon
42
Spyre Therapeutics
SYRE
$1.04B
$3.23M 0.3%
150,000
-60,000
-29% -$1.29M
KNSA icon
43
Kiniksa Pharmaceuticals
KNSA
$2.59B
$2.63M 0.25%
+150,000
New +$2.63M
DCTH icon
44
Delcath Systems
DCTH
$385M
$1.25M 0.12%
300,000
-744,444
-71% -$3.1M
IOBT icon
45
IO Biotech
IOBT
$115M
$928K 0.09%
493,827
– –
IMUX icon
46
Immunic
IMUX
$79.4M
$632K 0.06%
421,184
– –
NUVB.WS icon
47
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$71.4M
$4K ﹤0.01%
66,666
– –
ALXO icon
48
ALX Oncology
ALXO
$55.7M
– –
-1,000,000
Closed -$4.8M
NBIX icon
49
Neurocrine Biosciences
NBIX
$13.9B
– –
-150,000
Closed -$16.9M
ROIV icon
50
Roivant Sciences
ROIV
$8.6B
– –
-1,200,000
Closed -$14M
1
2
3